Related news:
CCI penalises investment manager of Goldman Sachs AIF for failing to notify Biocon deal - Biocon unit gets FDA nod for generic drug - Biocon Q1 profit up 6x at 660 crore - Biocon leads India push into weight loss drugs as patents lapse - Eris to buy Biocon arm's branded drugs for 1,242 crore - Eris to acquire branded formulations of Biocon subsidiary for Rs 1242 crore - What's 'pink tax' Biocon chief complained about? - Biocon Dec quarter revenue up 50% YoY - Hebbagodi residents want Biocon removed from stn name - Biocon subsidiary grants distribution of biosimilar to Sandoz in Japan
Biocon
Bookmark
ShareKey facts
- city: Bengaluru
- country: India
- sector: Health Care
- foundation year: 1978
- industry: Biotechnology
- CEO: Siddharth Mittal
- CEO gender: Male
Classified as: organization
Summary
Biocon is a company. It is located in Bengaluru, India and was founded in 1978. The company is part of the Health Care sector, specifically in the Biotechnology industry.
Business
Biocon is one of the 3,466,499 companies in our database.
- Assets: 2.6B $
- Debt: 650.3M $
- Employees: 15,000 people
- Market cap: 4.4B $
- Profits: 81.9M $
- Revenues: 1.1B $
Companies from India
Companies in the Biotechnology industry
Companies in the Health Care sector
Stocks from Biocon
Explore more on business
Talking Points:
- BioconIndia's largest biopharmaceutical company
- Biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex APIs
- Delivering Affordable Innovation
- Delivering Affordable Innovation. | Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthcare through ...
- Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.
Learn more about talking points
